Stockscreener 앱 받기
29.33
2.70%
0.77
시간 외 거래:
29.14
-0.19
-0.65%
전일 마감가:
$28.56
열려 있는:
$28.83
하루 거래량:
1.64M
Relative Volume:
0.94
시가총액:
$1.79B
수익:
$362.27M
순이익/손실:
$-85.19M
주가수익비율:
-20.23
EPS:
-1.45
순현금흐름:
$-68.71M
1주 성능:
+10.85%
1개월 성능:
-14.01%
6개월 성능:
+3.79%
1년 성능:
-30.55%
1일 변동 폭
$28.27
$29.56
1주일 범위
$24.41
$29.56
52주 변동 폭
$23.30
$55.33
트위스트 바이오사이언스 Stock (TWST) Company Profile
명칭
Twist Bioscience Corp
전화
800-719-0671
주소
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
TWST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
29.33 | 1.75B | 362.27M | -85.19M | -68.71M | -1.45 |
|
TMO
Thermo Fisher Scientific Inc
|
586.07 | 220.72B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.98 | 160.62B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
752.14 | 57.96B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
153.60 | 42.88B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
228.18 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
트위스트 바이오사이언스 Stock (TWST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-04 | 개시 | Stephens | Overweight |
| 2024-12-13 | 개시 | Wolfe Research | Outperform |
| 2024-06-04 | 개시 | Guggenheim | Buy |
| 2024-01-17 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-09-27 | 개시 | Berenberg | Buy |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2023-01-03 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2022-03-02 | 재개 | Cowen | Outperform |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-29 | 개시 | William Blair | Outperform |
| 2021-06-04 | 개시 | Goldman | Neutral |
| 2021-04-12 | 개시 | Piper Sandler | Overweight |
| 2021-02-05 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2020-10-20 | 개시 | SVB Leerink | Mkt Perform |
| 2019-05-31 | 개시 | Evercore ISI | Outperform |
| 2018-11-26 | 개시 | JP Morgan | Neutral |
모두보기
트위스트 바이오사이언스 주식(TWST)의 최신 뉴스
Insider Sell Alert: Jan Johannessen Sells Shares of Twist Biosci - GuruFocus
Can Twist Bioscience Corporation (0ME) stock reach $200 price targetWeekly Profit Report & Weekly Consistent Profit Watchlists - newser.com
Can Twist Bioscience Corporation stock surprise with earnings upside2025 Market Outlook & Stepwise Entry and Exit Trade Signals - newser.com
Why Twist Bioscience Corporation (0ME) stock could outperform next year - newser.com
Can Twist Bioscience Corporation (0ME) stock survive global slowdown2025 Investor Takeaways & Safe Investment Capital Preservation Plans - newser.com
Live market analysis of Twist Bioscience CorporationEarnings Recap Summary & Daily Profit Maximizing Trade Tips - newser.com
What does recent volatility data suggest for Twist Bioscience CorporationQuarterly Market Summary & Verified Chart Pattern Signals - newser.com
Is Twist Bioscience Corporation (0ME) stock undervalued at current priceMarket Sentiment Summary & Fast Momentum Stock Entry Tips - newser.com
Will Twist Bioscience Corporation (0ME) stock hit analyst forecastsJuly 2025 Fed Impact & Daily Growth Stock Tips - newser.com
What is the fair value estimate for Twist Bioscience Corporation (0ME) stock in 2025CPI Data & Weekly Top Performers Watchlists - newser.com
Stephens Initiates Twist Bioscience (TWST) With Overweight Rating, Sets $41 PT - Finviz
What Indicators Suggest Overbought Oversold Levels in Ascensive Educare LimitedHead and Shoulders Patterns & Get Free Training on Technical Indicators - earlytimes.in
What analysts say about Twist Bioscience Corporation stockTrading Psychology Tips & Exceptional Return Growth - earlytimes.in
Decoding Twist Bioscience Corp (TWST): A Strategic SWOT Insight - GuruFocus
Twist Bioscience at Wolfe Research Conference: Strategic Growth Amid Challenges - Investing.com
Barclays Lowers Price Target for Twist Bioscience (TWST) to $37. - GuruFocus
Is Twist Bioscience Corporation (TWST) a Compelling Risk-Regarded Opportunity? - Insider Monkey
Twist Bioscience Corp SEC 10-K Report - TradingView
Twist Bioscience (BIT:1TWST) Price Target Decreased by 11.71% to 31.98 - Nasdaq
Will Twist Bioscience Corporation outperform the marketJuly 2025 Closing Moves & Proven Capital Preservation Tips - newser.com
Twist Bioscience (TWST) Is Down 11.2% After Record Revenue and MRD Express Launch Plans Announced - Yahoo Finance
Twist Bioscience Corporation (NASDAQ:TWST) Q4 2025 Earnings Call Transcript - Insider Monkey
Twist Bioscience stock hits 52-week low at 23.85 USD By Investing.com - Investing.com Canada
Twist Bioscience: Fiscal Q4 Earnings Snapshot - Stamford Advocate
Earnings call transcript: Twist Bioscience Q4 2025 results miss forecasts By Investing.com - Investing.com Nigeria
STATE STREET CORP Increases Stake in Twist Bioscience Corp - GuruFocus
Cathie Wood’s ARK trims Pinterest stock, adds to Bitmine and Twist Bioscience - Investing.com Australia
Volatility clustering patterns for Twist Bioscience CorporationTrade Ideas & Low Risk Investment Opportunities - newser.com
Twist Bioscience Corp (TWST) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... By GuruFocus - Investing.com Canada
Twist Bioscience earnings missed by $0.04, revenue topped estimates - Investing.com South Africa
Twist Bioscience Corp (TWST) Q4 2025 Earnings Call Highlights: R - GuruFocus
Twist Bioscience Corp (TWST) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... - Yahoo Finance
Why Is Twist Bioscience Stock Tumbling Friday?Twist Bioscience (NASDAQ:TWST) - Benzinga
Is Twist Bioscience Corporation building a consolidation baseTrend Reversal & Capital Protection Trade Alerts - newser.com
Earnings call transcript: Twist Bioscience Q4 2025 results miss forecasts - Investing.com India
Twist Bioscience Q4 2025 slides: revenue growth continues as EBITDA breakeven nears - Investing.com
TWST Reports Positive Revenue Growth for Fiscal 2025 - GuruFocus
Twist Bioscience (TWST) Reports Strong Q4 Revenue and Anticipates Profitable Growth - GuruFocus
Twist Bioscience shares drop 9% on wider than expected Q4 loss - Investing.com Canada
Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
트위스트 바이오사이언스 (TWST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.35%
1.41%
자본화:
|
볼륨(24시간):